IRIS - Res&Arch Institutional Research Information System - Research & Archive

VERSO, Melina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.497
EU - Europa 1.143
AS - Asia 1.026
SA - Sud America 201
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 3.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.466
SG - Singapore 543
IE - Irlanda 237
IT - Italia 227
UA - Ucraina 190
BR - Brasile 176
RU - Federazione Russa 135
HK - Hong Kong 132
CN - Cina 131
VN - Vietnam 100
DE - Germania 91
SE - Svezia 75
FI - Finlandia 70
TR - Turchia 42
GB - Regno Unito 34
KR - Corea 21
CA - Canada 20
FR - Francia 18
AT - Austria 16
BE - Belgio 14
IN - India 11
PL - Polonia 9
BD - Bangladesh 8
NL - Olanda 8
ZA - Sudafrica 8
AR - Argentina 7
UZ - Uzbekistan 7
CH - Svizzera 5
IQ - Iraq 5
JO - Giordania 5
JP - Giappone 5
MX - Messico 5
LB - Libano 4
PK - Pakistan 4
VE - Venezuela 4
CO - Colombia 3
EC - Ecuador 3
EU - Europa 3
KE - Kenya 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
ID - Indonesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SV - El Salvador 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KZ - Kazakistan 1
MA - Marocco 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TN - Tunisia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.895
Salva come PNG Salva come JPEG
Città #
Singapore 349
Dublin 232
Chandler 215
San Mateo 133
Hong Kong 130
Jacksonville 111
Perugia 90
Ashburn 73
Altamura 70
Boardman 67
Santa Clara 67
Ann Arbor 66
Medford 61
Princeton 60
Lawrence 56
Moscow 46
Wilmington 46
Andover 41
Izmir 36
Munich 34
Ho Chi Minh City 28
Dong Ket 27
Des Moines 26
Los Angeles 26
Beijing 21
Seoul 21
New York 18
Saint Petersburg 17
Hanoi 16
Norwalk 15
Brussels 14
Helsinki 14
São Paulo 14
The Dalles 14
San Paolo di Civitate 13
Redmond 11
Turku 11
Brooklyn 8
Dallas 8
Rio de Janeiro 8
Rome 8
Johannesburg 7
Montreal 7
Piscataway 7
Redwood City 7
Seattle 7
Atlanta 6
New Orleans 6
Nuremberg 6
Stockholm 6
Vienna 6
Warsaw 6
Woodbridge 6
Amman 5
Belo Horizonte 5
Chicago 5
Denver 5
Shanghai 5
Toronto 5
Bologna 4
Boston 4
Falkenstein 4
Fortaleza 4
Goslar 4
Guangzhou 4
Haiphong 4
Parabiago 4
San Francisco 4
Tokyo 4
Charlotte 3
Chennai 3
Houston 3
Kocaeli 3
London 3
Manchester 3
Miami 3
Mumbai 3
Orem 3
Piracicaba 3
Porto Alegre 3
Vancouver 3
Amsterdam 2
Auckland 2
Biên Hòa 2
Bogotá 2
Brasília 2
Bắc Giang 2
Cabo Frio 2
Campo Grande 2
Caracas 2
Curitiba 2
Da Nang 2
Delhi 2
Den Haag 2
Dhaka 2
Falls Church 2
Guarulhos 2
Hòa Bình 2
Lima 2
Nairobi 2
Totale 2.542
Salva come PNG Salva come JPEG
Nome #
Epidemiology of cerebral vein and sinus thrombosis. 112
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 98
Risk factors for venous thromboembolism in the elderly: results of the master registry. 97
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 97
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 91
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 91
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 90
Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism 90
[Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. 88
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 84
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry 82
Epidemiology of cerebral vein and sinus thrombosis 82
A prospective study on survival in cancer patients with and without venous thromboembolism. 82
Chemotherapy-associatedthromboembolic risk in cancer outpatients and effect of nadroparinthromboprophylaxis: results of a retrospective analysis of the PROTECHT study. 81
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 80
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism 80
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter-related deep vein thrombosis in a child with acute lymphoblastic leukemia. 76
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. 75
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 75
Apixaban for the treatment of venous thromboembolism associated with cancer 75
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 74
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 74
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients 70
Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism. 68
A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry. 68
Do italian vascular centers look for isolated calf deep vein thrombosis? Analysis of isolated calf deep vein thromboses included in the ''Master'' Registry. 67
Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma 67
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). 64
Thromboprophylaxis during chemotherapy in patients with advanced cancer. 59
Treatment of venous thromboembolism in patients with cancer: What news from clinical trials? 59
Building effective prophylaxis of deep vein thrombosis in the outpatient setting. Blood Coagul Fibrinolysis. 58
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 57
New oral anticoagulants and their management in dental practice 57
Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism 57
Risk factors of catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. 56
Do antiangiogenics promote clot instability? Data from the TESEO prospective registry and Caravaggio clinical trial. 56
Seasonal variation in the occurrence of venous thromboembolism: data from the MASTER Registry. 54
Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry. 54
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study 54
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. 53
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. 53
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 53
Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the protecht and topic-2 studies. 52
Thromboprophylaxis during chemotherapy after advanced cancer. 52
Management of venous thromboembolism in patients with cancer. 50
PL-21 New and old anticoagulants in cancer. 50
Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus 48
Thrombosis and cancer: clinical relevance of a dangerous liaison. 48
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 48
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. 46
Therapy insight:venous-catheter-related thrombosis in cancer patients 46
Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer 46
Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life 46
Prophylaxis of upper limb deep vein thrombosis in cancer patients with central vein catheter 44
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 41
New strategies of VTE prevention in cancer patients. 40
To the editor: The effect of low-molecular-weight heparin in cancer patients: The mirror image of survival? 40
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer 40
The MASTER registry on venous thromboembolism: description of the study cohort. 39
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry 38
Prophylaxis against venous thromboembolism in patients with cancer [3] 38
Targeted anti-cancer agents and risk of venous thromboembolism 34
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 31
Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence 29
Totale 4.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.602
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021198 0 0 0 0 0 13 38 11 42 29 34 31
2021/2022505 8 86 8 13 24 4 5 161 6 45 70 75
2022/2023798 67 189 15 44 49 89 0 28 283 1 27 6
2023/2024228 18 25 24 3 3 0 39 9 7 14 50 36
2024/2025827 0 68 1 39 126 39 52 41 153 60 175 73
2025/2026831 128 102 95 159 224 123 0 0 0 0 0 0
Totale 4.004